Crinetics (CRNX) PT Lowered to $95 at Citizens After Q1 Results

May 8, 2026 4:51 AM

Citizens analyst Jonathan Wolleben lowered the price target on Crinetics (NASDAQ: CRNX) to $95.00 (from $97.00) while maintaining a Market ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found